Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1016/j.bjane.2013.06.020
Brazilian Journal of Anesthesiology
Clinical Informations

Sedation with dexmedetomidine for conducting electroencephalogram in a patient with Angelman syndrome: a case report

Sedação com dexmedetomidina para realização de eletroencefalograma em paciente portadora de síndrome de Angelmann: relato de caso

Magda Lourenço Fernandes; Maria do Carmo Santos; Renato Santiago Gomez

Downloads: 0
Views: 633

Abstract

ABSTRACT INTRODUCTION: Angelman syndrome is characterized by severe mental retardation and speech and seizure disorders. This rare genetic condition is associated with changes in GABAA receptor. Patients with Angelman syndrome need to be sedated during an electroencephalogram ordered for diagnostic purposes or evolutionary control. Dexmedetomidine, whose action is independent of GABA receptor, promotes a sleep similar to physiological sleep and can facilitate the performing of this examination in patients with Angelman syndrome. CASE REPORT: Female patient, 14 years old, with Angelman syndrome; electroencephalogram done under sedation with dexmedetomidine. The procedure was uneventful and bradycardia or respiratory depression was not recorded. The examination was successfully interpreted and epileptiform activity was not observed. CONCLUSION: Dexmedetomidine promoted satisfactory sedation, was well tolerated and enabled the interpretation of the electroencephalogram in a patient with Angelman syndrome and seizure disorder.

Keywords

Angelman syndrome, EEG, Deep sedation, Dexmedetomidine

Resumo

RESUMO INTRODUÇÃO: a síndrome de Angelman (SA) é caracterizada por retardo mental grave, distúrbio da fala e desordem convulsiva. Essa condição genética rara está associada a alterações do receptor GABA-A. Pacientes portadores de SA necessitam ser sedados durante a feitura de eletroencefalograma (EEG), indicado para fins diagnósticos ou controle evolutivo. A dexmedetomidina, cuja ação independe do receptor GABA, promove sono semelhante ao fisiológico e pode viabilizar a feitura desse exame em pacientes com SA. RELATO DE CASO: paciente feminina, 14 anos, portadora de SA, fez EEG sob sedação com dexmedetomidina. O procedimento transcorreu sem intercorrências e não foi registrada bradicardia ou depressão respiratória. O exame foi interpretado com sucesso e atividade epileptiforme não foi observada. CONCLUSÃO: a dexmedetomidina promoveu sedação satisfatória, foi bem tolerada e possibilitou a interpretação do EEG em paciente com SA e desordem convulsiva.

Palavras-chave

Síndrome de Angelman, Eletroencefalograma, Sedação profunda, Dexmedetomidina

References

Butler MG, Hayes BG, Hathaway MM, Begleiter ML. Specific genetic diseases at risk for sedation/anesthesia complications. Anesth Analg. 2000;91:837-55.

Jan MMS, Aquino MF. The use of chloral hydrate in pediatric electroencephalography. Neurosciences. 2001;6:99-102.

Ramanathan KR, Muthuswamy D, Jenkins BJ. Anaesthesia for Angelman syndrome. Anaesthesia. 2008;63:659-61.

Laan LA, Vein AA. Angelman syndrome is there a characteristic EEG?. Brain Dev. 2005;27:80-7.

Angelman H. ''Puppet'' children. A report on three cases. Dev Med Child Neurol. 1965;7:681-8.

Clayton-Smith J, Laan L. Angelman syndrome a review of the clinical and genetic aspects. J Med Genet. 2003;40:87-95.

Errando CL. Comments on a case report of Angelman syndrome anaesthesia. Anaesthesia. 2008;63:1145-6.

Thoresen M, Henriksen O, Wannag E, Laegreid L. Does a sedative dose of chloral hydrate modify the EEG of children with epilepsy. Electroencephalogr Clin Neurophysiol. 1997;102:152-7.

Rumm PD, Takao RT, Fox DJ, Atkinson SW. Efficacy of sedation of children with chloral hydrate. South Med J. 1990;83:1040-3.

Gertler R, Brown HC, Mitchell DH, Silvius EM. Dexmedetomidine a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14:13-21.

Huupponen E, Maksimow A, Lapinlampi P. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand. 2008;52:289-94.

Lubisch N, Roskos R, Berkenbosch JW. Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatr Neurol. 2009;41:88-94.

Ray T, Tobias JD. Dexmedetomidine for sedation during electroencephalographic analysis in children with autism, pervasive developmental disorders, and seizure disorders. J Clin Anesth. 2008;20:364-8.

5dcd922d0e8825322cbf58f1 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections